- Home
- GILT vs VNDA Comparison
GILT vs VNDA Comparison
Compare GILT & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILT
- VNDA
- Stock Information
- Founded
- GILT 1987
- VNDA 2002
- Country
- GILT Israel
- VNDA United States
- Employees
- GILT N/A
- VNDA N/A
- Industry
- GILT Radio And Television Broadcasting And Communications Equipment
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- GILT Technology
- VNDA Health Care
- Exchange
- GILT Nasdaq
- VNDA Nasdaq
- Market Cap
- GILT 281.1M
- VNDA 270.2M
- IPO Year
- GILT 1993
- VNDA 2006
- Fundamental
- Price
- GILT $5.48
- VNDA $5.17
- Analyst Decision
- GILT Strong Buy
- VNDA Strong Buy
- Analyst Count
- GILT 2
- VNDA 2
- Target Price
- GILT $8.50
- VNDA $15.50
- AVG Volume (30 Days)
- GILT 119.4K
- VNDA 775.4K
- Earning Date
- GILT 11-13-2024
- VNDA 11-06-2024
- Dividend Yield
- GILT N/A
- VNDA N/A
- EPS Growth
- GILT 229.32
- VNDA N/A
- EPS
- GILT 0.35
- VNDA N/A
- Revenue
- GILT $292,248,000.00
- VNDA $190,858,000.00
- Revenue This Year
- GILT $26.84
- VNDA $6.70
- Revenue Next Year
- GILT $22.06
- VNDA $51.03
- P/E Ratio
- GILT $15.69
- VNDA N/A
- Revenue Growth
- GILT 12.61
- VNDA N/A
- 52 Week Low
- GILT $4.04
- VNDA $3.30
- 52 Week High
- GILT $6.80
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- GILT 72.81
- VNDA 59.66
- Support Level
- GILT $5.06
- VNDA $4.56
- Resistance Level
- GILT $5.58
- VNDA $4.89
- Average True Range (ATR)
- GILT 0.11
- VNDA 0.18
- MACD
- GILT 0.04
- VNDA 0.04
- Stochastic Oscillator
- GILT 89.33
- VNDA 66.67
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs) and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.